Vanda Pharmaceuticals (VNDA) Other Accumulated Expenses (2011 - 2018)

Vanda Pharmaceuticals' Other Accumulated Expenses history runs 8 years deep, the most recent figure standing at $2.0 million for Q1 2018.

• In Q1 2018, Other Accumulated Expenses rose 8.93% year-over-year to $2.0 million; the TTM figure through Mar 2018 stood at $2.0 million (up 8.93% YoY), while the FY2017 annual figure was $2.0 million, up 75.84% from the prior year.
• Other Accumulated Expenses came in at $2.0 million for Q1 2018 at Vanda Pharmaceuticals, up from $2.0 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $2.0 million in Q1 2018 to a low of $614000.0 in Q1 2014.
• A 5-year average of $1.5 million and a median of $1.6 million in 2015 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses surged 4555.56% in 2014 and plunged 32.66% in 2016, its largest moves.
• Vanda Pharmaceuticals' Other Accumulated Expenses stood at $2.0 million in 2014, then dropped by 16.63% to $1.7 million in 2015, then slumped by 32.66% to $1.1 million in 2016, then soared by 75.84% to $2.0 million in 2017, then rose by 1.5% to $2.0 million in 2018.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $2.0 million, $2.0 million, and $1.9 million for Q1 2018, Q4 2017, and Q3 2017 respectively.

Peer Comparison